Knight Therapeutics (OTCMKTS:KHTRF) Trading Down 8.5% – Here’s Why
by Doug Wharley · The Cerbat GemKnight Therapeutics Inc. (OTCMKTS:KHTRF – Get Free Report)’s share price traded down 8.5% on Monday . The company traded as low as $4.32 and last traded at $4.32. 1,338 shares traded hands during mid-day trading, a decline of 61% from the average session volume of 3,423 shares. The stock had previously closed at $4.7226.
Knight Therapeutics Stock Performance
The firm’s 50 day moving average price is $4.40 and its 200-day moving average price is $4.38.
About Knight Therapeutics
Knight Therapeutics Inc (OTCMKTS:KHTRF) is a specialty pharmaceutical company headquartered in Montreal, Canada, focused on acquiring, in-licensing and commercializing innovative branded products for the Canadian and Latin American markets. The company secures exclusive marketing and distribution rights to medicines across multiple therapeutic areas, including ophthalmology, pain management, hematology and women’s health. Its portfolio features both prescription pharmaceuticals and specialty products that address unmet patient needs through targeted treatments.
Operating primarily in Canada, Mexico and select Latin American countries, Knight has established strategic alliances with global pharmaceutical firms to introduce novel therapies at various stages of development.